MarketInOut Stock Screener Log In | Sign Up

Adial Pharmaceuticals Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/28/2026
Adial Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization9.74 mln
Float2.38 mln
Earnings Date11/18/2026

Piotroski F-Score

2 / 9
Weak

Relative Strength

100 / 100
Top performer

ROE

-2,012
Deeply negative

ROA

-539
Deeply negative

Business Description

Adial Pharmaceuticals is a Virginia-based drug development company working to help people overcome addiction and manage pain without opioids. Its most advanced treatment, AD04, is currently in late-stage clinical trials aimed at reducing harmful alcohol use. Founded in 2010, the company continues to expand its pipeline of potential therapies targeting a range of conditions.

Key Fundamentals

EPS-20.65
ROE-2,012
ROIC-885
ROA-539
EBITDA, mln-57.80
EV / EBITDA-0.85
EV / EBIT-0.85

Quote Details

Last 5.05
Change 1.34 (36.12%)
Open 3.98
Volume 82,629
Turnover 417,276
Average Volume 34,785

Financial Ratios

Leverage Ratio186
Current Ratio5.63
Price / Book110

Financial Strength

Piotroski F-Score 2 / 9
Short Ratio3.79
Short % of Float7.01

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 22.87% 98 / 100   
1 Month 21.69% 97 / 100   
2 Months 88.43% 99 / 100   
6 Months 226% 99 / 100   
1 Year -44.63% 20 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog